SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 17, 2026

GLUE

Monte Rosa Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $322K total
Actionable Insight • Neutral

This insider selling cluster is routine and immaterial relative to GLUE's $2.1B market cap. The sales are likely liquidity-driven (vesting/exercise-related) and carry no bearish signal. Monitor next quarterly filing for pipeline updates on the company's lead programs, which are the primary value drivers for this clinical-stage biotech.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
GLUE ▼ -57.88% at T+60d
NEUTRAL call -57.88% · α vs SPY -62.72% · entry $23.48 → $9.89
Entry = T+0 close
Jul 17, 2026
via day close
T+1d
+0.64%
call +0.64% · α -0.20%
$23.63
settled 3mo ago
T+5d
-3.92%
call -3.92% · α -3.51%
$22.56
settled 3mo ago
T+20d
-34.50%
call -34.50% · α -38.62%
$15.38
settled 2mo ago
T+60d
-57.88%
call -57.88% · α -62.72%
$9.89
settled 14d ago

Price Chart

Loading chart...

Executive Summary

President & CEO Markus Warmuth and COO Jennifer Champoux sold a combined $322K in open-market sales over two days, with Champoux also exercising derivatives. At a $2.1B market cap, the sales represent ~0.015% of market cap — well below the 0.1% materiality threshold, making this a routine liquidity-driven event. The cluster is not informative per academic literature, as insider sales are weak predictors and the dollar amounts are trivial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$321.9K
Insiders
2

Key Facts

  • President & CEO Markus Warmuth sold 9,500 shares at $23.18 for $220,219 on 2026-07-16
  • COO Jennifer Champoux sold 4,351 shares at $23.38 for $101,730 on 2026-07-15
  • Champoux also exercised derivative securities for 4,351 shares at $3.98 ($17,317) and 4,351 shares at $0 (non-cash)
  • Total open-market sales: $321,948, representing ~0.015% of $2.1B market cap
  • No open-market purchases in the cluster

Financial Impact

Total insider sales of $322K, or ~0.015% of market cap — immaterial

insider ownership

Risk Factors

  • Insider selling could increase if the stock continues to appreciate, but current levels are trivial
  • No bearish signal from this cluster — the primary risk remains clinical trial outcomes

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GLUE-1784355138398
19 reports for GLUE
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 4 best @ T+60▲ +18.17%Apr 20, 2026
Filters
Rows
Reports for GLUE — sortable, filterable
TypeNow
Oct 1, 2026
25d ago
8-K
BULLISH ★ 7/10
$11.26awaiting T+60—$10.41 (−7.55%)
Sep 30, 2026
25d ago
Press Release
NEUTRAL ★ 5/10
$11.26awaiting T+60—$10.41 (−7.55%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$15.71awaiting T+60—$10.41 (−33.74%)
Jul 17, 2026
14w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.48 $9.89▼ −57.88%▼ −62.72%$10.41 (−55.66%)
Jul 7, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.06 $11.93▼ −50.42%▼ −52.73%$10.41 (−56.73%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.41 (−57.00%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.41 (−57.00%)
Jun 29, 2026
16w ago
144
NEUTRAL ★ 2/10
$24.20 $11.89▼ −50.87%▼ −54.43%$10.41 (−56.98%)
Jun 25, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.29 $12.60▼ −43.47%▼ −49.56%$10.41 (−53.30%)
Jun 2, 2026
20w ago
Insider Cluster
NEUTRAL ★ 3/10
$17.59 $14.32▼ −18.59%▼ −21.09%$10.41 (−40.82%)
Showing 10 of 19

US Market Status

Market Open — Closes in 3h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 18, 2026